+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Veterinary Molecular Diagnostic System Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6134377
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Veterinary Molecular Diagnostic System Market is projected to reach USD 1.48 Billion in 2026. It is expected to continue growing at a CAGR of 9.41%, reaching USD 2.54 Billion by 2032.

Veterinary Molecular Diagnostics: Executive Overview

Veterinary molecular diagnostic systems apply nucleic-acid testing and related molecular techniques to detect pathogens, genetic conditions, and clinically relevant biomarkers in animals. Their value is strongest where rapid, specific results can support treatment selection, herd management, outbreak control, food-chain protection, and surveillance across companion-animal, livestock, aquaculture, and wildlife settings.

Shifts Toward Faster, Decentralized Veterinary Testing

The landscape is shifting from centralized, laboratory-intensive workflows toward integrated systems that combine sample preparation, amplification, detection, and reporting with fewer manual steps. Demand for faster turnaround is reinforced by antimicrobial-resistance concerns, transboundary animal diseases, biosecurity requirements, and the need to manage high-throughput screening in production environments. Adoption also depends on sample quality, validation across species, workflow interoperability, operator training, reimbursement conditions, and regulatory acceptance.

Artificial Intelligence Enhances Interpretation and Workflow Control

Artificial intelligence can strengthen molecular diagnostics by supporting image and signal interpretation, quality-control checks, anomaly detection, epidemiological pattern recognition, and prioritization of confirmatory testing. Its practical contribution depends on representative veterinary datasets, transparent validation, human oversight, cybersecurity, and integration with laboratory information systems. AI is therefore most useful as an augmentation layer that improves consistency and triage rather than as a substitute for validated assays or veterinary judgment.

Regional Differences Reflect Disease Burden, Infrastructure, and Regulation

North America combines advanced veterinary infrastructure, established laboratory networks, and strong demand for companion-animal and livestock testing. Europe emphasizes animal-health surveillance, traceability, antimicrobial stewardship, and harmonized standards, while Asia-Pacific spans sophisticated urban diagnostics and rapidly developing production systems with varied laboratory capacity. Latin America places substantial emphasis on livestock health, export assurance, and outbreak monitoring. The Middle East faces distinctive priorities linked to livestock production, import controls, and transboundary disease preparedness. Africa presents significant opportunities for decentralized and field-adapted systems, although affordability, logistics, power reliability, and laboratory access remain important implementation considerations.

Group-Level Priorities Shape Procurement and Adoption

ASEAN priorities include cross-border surveillance, aquaculture and livestock health, and solutions suited to diverse laboratory environments. BRICS members reflect broad needs spanning large production systems, public veterinary services, research capacity, and uneven access to advanced testing. The European Union emphasizes harmonized surveillance, food safety, and regulatory alignment. G7 markets generally support sophisticated diagnostics, quality systems, and data integration. GCC countries prioritize import biosecurity, livestock productivity, and centralized or well-connected testing networks. NATO members may also value preparedness for biological threats affecting animal health, food security, and operational resilience, while national regulatory and procurement practices remain decisive.

Country Perspectives Highlight Diverse Use Cases

Australia emphasizes biosecurity, livestock surveillance, and geographically distributed testing. Brazil combines major livestock and poultry systems with needs for export-oriented diagnostics and outbreak control. Canada and the United States support advanced companion-animal, food-animal, research, and public-sector applications. China and India present broad demand across production animals, aquaculture, veterinary hospitals, and surveillance programs, with varied regional infrastructure. Japan and South Korea place importance on quality, speed, and technology-enabled clinical workflows. France, Germany, Italy, Spain, and the United Kingdom align molecular testing with animal-health services, food-chain assurance, research, and regulatory surveillance. Mexico prioritizes livestock health, trade-related testing, and improved regional access. Russia’s requirements include large-scale production monitoring, veterinary control, and resilience across geographically dispersed systems.

Prioritize Validated, Connected, and Field-Ready Diagnostic Workflows

Industry leaders should first match assay menus and instrument formats to clearly defined species, diseases, sample types, and decision timelines. They should validate performance locally, establish quality-control and confirmatory-testing pathways, and design procurement around total workflow requirements rather than instrument features alone. Partnerships with veterinary laboratories, universities, producers, and public-health agencies can improve evidence generation and surveillance utility. Investments in interoperable reporting, workforce training, maintenance support, supply continuity, cybersecurity, and responsible AI governance will help convert technical capability into dependable clinical and population-health outcomes.

Methodology for a Evidence-Based Veterinary Diagnostic Assessment

This executive summary uses a structured review of the veterinary molecular diagnostic system landscape, organized around technology applications, animal-health workflows, regulatory and surveillance needs, infrastructure conditions, and regional implementation factors. Insights are synthesized from verifiable public information such as government and intergovernmental guidance, peer-reviewed research, regulatory materials, laboratory standards, and documented veterinary practice patterns. Claims are framed qualitatively to avoid unsupported estimates, and regional, group, and country observations are interpreted in light of differences in disease priorities, production systems, laboratory capacity, and policy environments.

Reliable Molecular Testing Supports More Resilient Animal Health Systems

Veterinary molecular diagnostic systems are increasingly important for timely detection, targeted intervention, antimicrobial stewardship, biosecurity, and coordinated surveillance. The strongest opportunities are likely to arise where validated assays, practical workflows, connected data systems, and trained users are combined with local disease knowledge and sustainable service models. Progress will depend less on technology alone than on fit with veterinary practice, regulatory expectations, infrastructure, and the operational realities of diverse animal-health settings.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Veterinary Molecular Diagnostic System Market, by Disease Category
7.1. Introduction
7.2. Genetic Diseases
7.3. Infectious Diseases
7.3.1. Bacterial
7.3.1.1. E coli
7.3.1.2. Mycobacterium
7.3.1.3. Salmonella
7.3.2. Fungal
7.3.3. Parasitic
7.3.4. Viral
7.3.4.1. Avian Influenza
7.3.4.2. Equine Infectious Anemia
7.3.4.3. Porcine Reproductive Respiratory Syndrome
7.4. Metabolic Diseases
7.5. Oncology Diagnostics
8. Veterinary Molecular Diagnostic System Market, by Technology
8.1. Introduction
8.2. Isothermal Amplification
8.3. Next Generation Sequencing
8.4. PCR
8.4.1. Conventional PCR
8.4.2. Digital PCR
8.4.3. Real Time PCR
9. Veterinary Molecular Diagnostic System Market, by Species
9.1. Introduction
9.2. Companion Animals
9.2.1. Canine
9.2.2. Equine
9.2.3. Feline
9.3. Livestock
9.3.1. Bovine
9.3.2. Porcine
9.3.3. Poultry
10. Veterinary Molecular Diagnostic System Market, by Sample Type
10.1. Introduction
10.2. Blood
10.3. Fecal
10.4. Swab
10.4.1. Nasal Swab
10.4.2. Oral Swab
10.5. Tissue
10.5.1. Muscle Tissue
10.5.2. Organ Biopsy
11. Veterinary Molecular Diagnostic System Market, by End User
11.1. Introduction
11.2. Diagnostic Laboratories
11.2.1. Hospital Based Diagnostics
11.2.2. Standalone Diagnostics
11.3. Research Institutes
11.3.1. Academic Laboratories
11.3.2. Contract Research Organizations
11.4. Veterinary Hospitals & Clinics
11.4.1. Mixed Animal Hospitals
11.4.2. Small Animal Hospitals
12. Veterinary Molecular Diagnostic System Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Veterinary Molecular Diagnostic System Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Veterinary Molecular Diagnostic System Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Agilent Technologies, Inc.
16.2. Bio-Rad Laboratories, Inc.
16.3. IDEXX Laboratories, Inc.
16.4. Merck & Co., Inc.
16.5. Neogen Corporation
16.6. PerkinElmer, Inc.
16.7. QIAGEN N.V.
16.8. Seegene Inc.
16.9. Synbiotics Corporation
16.10. Thermo Fisher Scientific Inc.
16.11. Zoetis Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Veterinary Molecular Diagnostic System Market, Years Considered for the Study
FIGURE 2. Global Veterinary Molecular Diagnostic System Market, Research Design
FIGURE 3. Global Veterinary Molecular Diagnostic System Market, Research Framework
FIGURE 4. Global Veterinary Molecular Diagnostic System Market, Data Triangulation
FIGURE 5. Global Veterinary Molecular Diagnostic System Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2025 vs 2032 (%)
FIGURE 7. Global Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Veterinary Molecular Diagnostic System Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Veterinary Molecular Diagnostic System Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Veterinary Molecular Diagnostic System Market Size, by Species, 2025 vs 2032 (%)
FIGURE 11. Global Veterinary Molecular Diagnostic System Market Size, by Species, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 13. Global Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Veterinary Molecular Diagnostic System Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Veterinary Molecular Diagnostic System Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Veterinary Molecular Diagnostic System Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Veterinary Molecular Diagnostic System Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Veterinary Molecular Diagnostic System Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Veterinary Molecular Diagnostic System Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Veterinary Molecular Diagnostic System Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Veterinary Molecular Diagnostic System Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Veterinary Molecular Diagnostic System Market Segmentation & Coverage
TABLE 2. Global Veterinary Molecular Diagnostic System Market Size, 2017-2032 (USD Million)
TABLE 3. Global Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
TABLE 4. Global Genetic Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Genetic Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Genetic Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Bacterial Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Bacterial Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Bacterial Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global E coli Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global E coli Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global E coli Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Mycobacterium Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Mycobacterium Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Mycobacterium Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Salmonella Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Salmonella Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Salmonella Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Fungal Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Fungal Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Fungal Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Parasitic Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Parasitic Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Parasitic Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Viral Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Viral Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Viral Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Avian Influenza Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Avian Influenza Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Avian Influenza Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Equine Infectious Anemia Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Equine Infectious Anemia Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Equine Infectious Anemia Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Porcine Reproductive Respiratory Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Porcine Reproductive Respiratory Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Porcine Reproductive Respiratory Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Metabolic Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Metabolic Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Metabolic Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Oncology Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Oncology Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Oncology Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 47. Global Isothermal Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Isothermal Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Isothermal Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Conventional PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Conventional PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Conventional PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Digital PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Digital PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Digital PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Real Time PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Real Time PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Real Time PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
TABLE 66. Global Companion Animals Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Companion Animals Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Companion Animals Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Canine Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Canine Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Canine Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Equine Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Equine Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Equine Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Feline Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Feline Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Feline Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Livestock Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Livestock Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Livestock Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Bovine Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Bovine Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Bovine Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Porcine Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Porcine Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Porcine Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Poultry Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Poultry Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Poultry Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 91. Global Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Fecal Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Fecal Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Fecal Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Swab Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Swab Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Swab Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Nasal Swab Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Nasal Swab Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Nasal Swab Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Oral Swab Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Oral Swab Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Oral Swab Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Tissue Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Tissue Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Tissue Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Muscle Tissue Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Muscle Tissue Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Muscle Tissue Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Organ Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Organ Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Organ Biopsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Hospital Based Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Hospital Based Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Hospital Based Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Standalone Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Standalone Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Standalone Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Academic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Academic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Academic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Veterinary Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Veterinary Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Veterinary Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Mixed Animal Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Global Mixed Animal Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. Global Mixed Animal Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. Global Small Animal Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Global Small Animal Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. Global Small Animal Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 143. Global Veterinary Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
TABLE 146. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 147. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 148. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
TABLE 149. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 150. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
TABLE 151. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 154. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Veterinary Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 161. North America Veterinary Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. North America Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
TABLE 163. North America Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 164. North America Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 165. North America Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
TABLE 166. North America Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 167. North America Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
TABLE 168. North America Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
TABLE 169. North America Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 170. North America Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 171. North America Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 172. North America Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
TABLE 173. North America Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 174. North America Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. North America Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 176. North America Veterinary Molecular Diagnostic System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 177. North America Veterinary Molecular Diagnostic System Market Size, by Veterinary Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 178. Latin America Veterinary Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Latin America Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
TABLE 180. Latin America Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 181. Latin America Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 182. Latin America Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
TABLE 183. Latin America Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 184. Latin America Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
TABLE 185. Latin America Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
TABLE 186. Latin America Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 187. Latin America Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 188. Latin America Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 189. Latin America Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
TABLE 190. Latin America Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 191. Latin America Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. Latin America Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 193. Latin America Veterinary Molecular Diagnostic System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 194. Latin America Veterinary Molecular Diagnostic System Market Size, by Veterinary Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 195. Europe Veterinary Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
TABLE 196. Europe Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
TABLE 197. Europe Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 198. Europe Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 199. Europe Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
TABLE 200. Europe Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 201. Europe Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
TABLE 202. Europe Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
TABLE 203. Europe Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 204. Europe Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 205. Europe Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 206. Europe Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
TABLE 207. Europe Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 208. Europe Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Europe Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 210. Europe Veterinary Molecular Diagnostic System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 211. Europe Veterinary Molecular Diagnostic System Market Size, by Veterinary Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 212. Middle East Veterinary Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
TABLE 213. Middle East Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
TABLE 214. Middle East Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 215. Middle East Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 216. Middle East Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
TABLE 217. Middle East Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 218. Middle East Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
TABLE 219. Middle East Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
TABLE 220. Middle East Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 221. Middle East Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 222. Middle East Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 223. Middle East Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
TABLE 224. Middle East Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 225. Middle East Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. Middle East Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 227. Middle East Veterinary Molecular Diagnostic System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 228. Middle East Veterinary Molecular Diagnostic System Market Size, by Veterinary Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 229. Africa Veterinary Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
TABLE 230. Africa Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
TABLE 231. Africa Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 232. Africa Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 233. Africa Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
TABLE 234. Africa Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 235. Africa Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
TABLE 236. Africa Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
TABLE 237. Africa Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 238. Africa Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 239. Africa Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 240. Africa Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
TABLE 241. Africa Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 242. Africa Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. Africa Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 244. Africa Veterinary Molecular Diagnostic System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 245. Africa Veterinary Molecular Diagnostic System Market Size, by Veterinary Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 246. Global Veterinary Molecular Diagnostic System Market Size, by Group, 2017-2032 (USD Million)
TABLE 247. ASEAN Veterinary Molecular Diagnostic System Market Size, by Group, 2017-2032 (USD Million)
TABLE 248. ASEAN Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
TABLE 249. ASEAN Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 250. ASEAN Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 251. ASEAN Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
TABLE 252. ASEAN Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 253. ASEAN Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
TABLE 254. ASEAN Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
TABLE 255. ASEAN Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 256. ASEAN Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 257. ASEAN Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 258. ASEAN Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
TABLE 259. ASEAN Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 260. ASEAN Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. ASEAN Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 262. ASEAN Veterinary Molecular Diagnostic System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 263. ASEAN Veterinary Molecular Diagnostic System Market Size, by Veterinary Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 264. GCC Veterinary Molecular Diagnostic System Market Size, by Group, 2017-2032 (USD Million)
TABLE 265. GCC Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
TABLE 266. GCC Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 267. GCC Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 268. GCC Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
TABLE 269. GCC Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 270. GCC Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
TABLE 271. GCC Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
TABLE 272. GCC Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 273. GCC Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 274. GCC Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 275. GCC Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
TABLE 276. GCC Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 277. GCC Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. GCC Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 279. GCC Veterinary Molecular Diagnostic System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 280. GCC Veterinary Molecular Diagnostic System Market Size, by Veterinary Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 281. European Union Veterinary Molecular Diagnostic System Market Size, by Group, 2017-2032 (USD Million)
TABLE 282. European Union Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
TABLE 283. European Union Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 284. European Union Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 285. European Union Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
TABLE 286. European Union Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 287. European Union Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
TABLE 288. European Union Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
TABLE 289. European Union Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 290. European Union Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 291. European Union Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 292. European Union Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
TABLE 293. European Union Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 294. European Union Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 295. European Union Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 296. European Union Veterinary Molecular Diagnostic System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 297. European Union Veterinary Molecular Diagnostic System Market Size, by Veterinary Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 298. BRICS Veterinary Molecular Diagnostic System Market Size, by Group, 2017-2032 (USD Million)
TABLE 299. BRICS Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
TABLE 300. BRICS Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 301. BRICS Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 302. BRICS Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
TABLE 303. BRICS Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 304. BRICS Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
TABLE 305. BRICS Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
TABLE 306. BRICS Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 307. BRICS Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 308. BRICS Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 309. BRICS Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
TABLE 310. BRICS Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 311. BRICS Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 312. BRICS Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 313. BRICS Veterinary Molecular Diagnostic System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 314. BRICS Veterinary Molecular Diagnostic System Market Size, by Veterinary Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 315. G7 Veterinary Molecular Diagnostic System Market Size, by Group, 2017-2032 (USD Million)
TABLE 316. G7 Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
TABLE 317. G7 Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 318. G7 Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 319. G7 Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
TABLE 320. G7 Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 321. G7 Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
TABLE 322. G7 Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
TABLE 323. G7 Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 324. G7 Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 325. G7 Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 326. G7 Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
TABLE 327. G7 Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 328. G7 Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 329. G7 Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 330. G7 Veterinary Molecular Diagnostic S

Companies Mentioned

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • IDEXX Laboratories, Inc.
  • Merck & Co., Inc.
  • Neogen Corporation
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Seegene Inc.
  • Synbiotics Corporation
  • Thermo Fisher Scientific Inc.
  • Zoetis Inc.